Targeting strategies in photodynamic therapy for cancer treatment

[1]  J. Jankun.  Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy. , 2011, International journal of oncology.

[2]  F. Guillemin,et al.  Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo. , 2009, Journal of photochemistry and photobiology. B, Biology.

[3]  C. Frochot,et al.  Design and photophysical properties of new RGD targeted tetraphenylchlorins and porphyrins , 2008 .

[4]  Hui Li,et al.  Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment , 2007, International journal of nanomedicine.

[5]  M. Lewis,et al.  Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer. , 2006, Archives of oral biology.

[6]  Z. Malik,et al.  Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells , 2006, British Journal of Cancer.

[7]  T. Hasan,et al.  Targeted photodynamic therapy , 2006, Lasers in surgery and medicine.

[8]  Joan W. Miller,et al.  Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. , 2004, Archives of ophthalmology.

[9]  G. Bormans,et al.  In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1. , 2004, Nuclear medicine and biology.

[10]  J. Reubi.  Peptide receptors as molecular targets for cancer diagnosis and therapy. , 2003, Endocrine reviews.

[11]  Shafiullah,et al.  Synthesis and biological activities of phthalocyanine-estradiol conjugates. , 2003, Bioorganic & medicinal chemistry letters.

[12]  T. Nyokong,et al.  Syntheses and photochemical properties of octasubstituted phthalocyaninato zinc complexes , 2001 .

[13]  G. Morelli,et al.  Synthesis and solution characterization of a porphyrin‐CCK8 conjugate , 2001, Journal of peptide science : an official publication of the European Peptide Society.

[14]  M. P. Kirpichnikov,et al.  Targeting Phthalocyanines to Tumor Cells Using Epidermal Growth Factor Conjugates , 1999, Tumor Biology.

[15]  G. Jori,et al.  CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. , 1994, British Journal of Cancer.

[16]  R. Knuechel,et al.  Combined chemotherapeutic and photodynamic treatment on human bladder cells by hematoporphyrin-platinum(II) conjugates. , 2004, Cancer letters.